(Q40963279)

25 September 2017

1 reference

title

Inotropic therapy for the failing myocardium (English)

1 reference

25 September 2017

Shipley JB

1

1 reference

PubMed ID

8590529

25 September 2017

Hess ML

series ordinal

2

1 reference

25 September 2017

1 November 1995

1 reference

25 September 2017

1 reference

25 September 2017

18

1 reference

25 September 2017

615-619

1 reference

25 September 2017

11

1 reference

Origin of myocardial depressant factor in shock

25 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181106

7 January 2021

STUDIES ON DIGITALIS. IV. OBSERVATIONS IN MAN ON THE EFFECTS OF DIGITALIS PREPARATIONS ON THE CONTRACTILITY OF THE NON-FAILING HEART AND ON TOTAL VASCULAR RESISTANCE.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181106

7 January 2021

Inotropic drugs and their mechanisms of action

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181106

7 January 2021

Reflex cardiovascular control in congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181106

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181106

7 January 2021

Review of randomized trials of digoxin therapy in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181106

7 January 2021

Newer catecholamines for treatment of heart failure and shock: An update on dopamine and a first look at dobutamine

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181106

7 January 2021

Sustained hemodynamic improvement during long-term therapy with levodopa in heart failure: role of plasma catecholamines.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181106

7 January 2021

Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181106

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181106

7 January 2021

Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181106

7 January 2021

Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181106

7 January 2021

Hydralazine therapy in chronic congestive heart failure. Sustained central and regional hemodynamic responses

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960181106

7 January 2021

Identifiers

DOI

10.1002/CLC.4960181106

1 reference

25 September 2017

1 reference

PubMed ID

8590529